Post-Market Surveillance in the Medical Device Industry

Post-Market Surveillance in the medical device industry is essential to ensure ongoing safety and performance after market approval. A strong Post-Market Surveillance in the medical device industry system helps manufacturers monitor real-world device performance and protect patient health.

Post-Market Surveillance in the medical device industry involves continuous data collection, analysis, and risk evaluation through adverse event reports, customer feedback, clinical follow-ups, and regulatory databases. This process supports patient safety, regulatory compliance, and continuous improvement.

Under EU MDR and FDA 21 CFR Part 822, Post-Market Surveillance in the medical device industry requires structured PMS plans, periodic safety update reports (PSUR), and proactive risk management—especially for Class II and Class III devices.

An effective Post-Market Surveillance in the medical device industry framework strengthens compliance, enhances device quality, and builds trust among regulators, healthcare providers, and patients.